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The aim of thrombolysis, angioplasty, and coronary artery bypass surgery is to "reperfuse"
ischemic myocardium; however, reperfusion can cause further cardiac damage and com-
promise the coronary microcirculation. Because nutrient supply and exchange and delivery of
pharmacologic agents require a patent microvasculature, the coronary microcirculation plays a
major role in myocardial recovery from ischemia. It is known that ischemia-reperfusion can
cause an increase in coronary permeability and microvascular plugging (No-reflow). The
permeability to macromolecules is increased more than the permeability to smaller molecules.
The permeability increase leads to extravasation of plasma proteins and a permeability edema.
Furthermore, proteins that normally remain extravascular are now free to wash out the heart.
Both microvascular effects, increased coronary permeability and No-reflow, compromise car-
diac function. The degree of damage depends on the nature (No-flow versus low-flow) and
length of ischemia. Unfortunately, both the increase in coronary permeability and the reduc-
tion in perfused capillarity advance with time during early reperfusion. Although the increase
in permeability does not require the presence of platelets or leukocytes, it is apparent that the
No-reflow response does. Mechanisms that may explain the microvascular responses to isch-
emia include cell swelling, damage caused by oxygen free radicals, and inflammatory responses
that may or may not involve granulocytes. The permeability response may involve a calcium-
mediated endothelial contraction because the macromolecular leakage that follows ischemia
can be prevented by pretreating hearts with the calcium blocker nisoldipine. Protection of the
coronary microcirculation should be included in any attempt to improve treatment ofocclusive
coronary artery disease.
INTRODUCTION
Modern man is painfully aware of the deleterious effects of myocardial ischemia.
Heart attacks and stroke, which have similar etiologies, are two major killers. In
most cases, the cause of organ failure is secondary to some compromse of the car-
diovascular system. Angioplasty, thrombolysis, and coronary bypass surgery all at-
tempt to remedy the vascular cause of cardiac damage. Similar methodologies are
used to treat stroke. Currently, attempts are being made not only to correct the
vascular problem but also to preserve or protect organ function by enhancing cell
metabolism or by preventing cell necrosis. These efforts at protection are certainly
worthwhile but usually do not consider a critical problem or consequence of
ischemia: damage to the microcirculation.
Microvascular damage is an important consideration because it is at the level of
microvessels that the principal functions of the cardiovascular system take place. In
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All rights of reproduction in any form reserved.the terminal vascular bed, blood-tissue exchange ofnutrients and waste products oc-
curs. It is also at this level that local blood flow is controlled and fluid balance is
maintained [1]. If microvascular integrity is compromised irreversibly by ischemia,
substrate supply may be reduced, and pharmacologic agents designed to protect cells
would probably be useless, because they have no avenue to reach the target tissues.
With this introduction two questions arise: How significant is the microvascular
damage due to ischemia? And, if it is important, what can be done about it? The
purpose of this paper is to describe studies, largely from our laboratory, that were
designed to address these questions. We have been particularly interested in preserv-
ing microvascular function in the heart [2,3,4] and more recently have performed
studies aimed at attenuating the effects of ischemia on the hepatic microcirculation
[5].
Initial Studies ofMyocardial Ischemia-Reperfusion
To gain an understanding of the coronary microvascular damage caused by
myocardial ischemia, we required a model that would reliably mimic the pathology
and allow assessment of microvascular function. The literature indicated that
ischemia followed by reperfusion lead often, but not always to edema and cell swell-
ing [6], appearance of plasma proteins in cardiac lymph [7], and possible changes in
microvessel ultrastructure [8,9,10,11]. These microvascular alterations occurred
simultaneously with decreased metabolism and cardiac function. The degree ofthese
deleterious changes was a function of the animal species studied, the length of
ischemia, and the length of reperfusion after ischemia. Other important considera-
tions were the type of ischemia: low-flow versus no-flow, regional versus global.
Furthermore, the degree of coronary "collateralization" appeared to be an impor-
tant consideration in interpreting results of ischemia-reperfusion studies [12].
Initially, we chose to study a dog model of global myocardial ischemia. Because
of our interests in cardiac protection during surgery, we developed a model of car-
diopulmonary bypass with separately controlled coronary perfusion and collection
of coronary venous return. This model proved to be quite versatile [2,13] and was
employed in other cardiac protection studies as well [14]. Because theprincipal func-
tion of any microcirculation is transvascular exchange, we used techniques to assess
the capacity of the coronary microcirculation to exchange solutes before and after
ischemia. In addition, myocardial oxygen delivery, myocardial oxygen extraction,
and cardiac water content were measured to correlate with the solute exchange
results.
To assess transcoronary solute exchange, we used the reference indicator tech-
nique popularized by Crone [15,16]. Measurements of the myocardial extraction of
radiolabeled inulin (5,200 MW) and albumin (BSA) (69,000 MW) were made during
a single pass through the coronary bed. This technqiue required injection of an in-
travascular reference tracer along with the diffusible test tracers. Because earlier
studies suggested that plasma albumin leaked into the tissue space after ischemia
[7,17], red cells labeled with technetium-99m were chosen as the intravascular
reference tracer. Recent studies by us [18] and others [19,20] confirmed that marked
extravasation of plasma protein followed ischemia. We chose to evaluate the effects
of 45 minutes of global normothermic ischemia because this insult caused moderate
damage with roughly 60 percent recovery of cardiac function after reperfusion.
Also, there was evidence in the literature that this length of ischemia did not lead to
extravasation of red cells [8]. In our initial studies, we found that roughly 50 percent
ofthe injected inulin was extracted in a single pass as it transversed the coronary bed
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[21]. This myocardial extraction was five to ten times the inulin extraction reported
earlier by others in working hearts [22,23]. The larger value of inulin extraction ob-
served in our study was caused most likely by the conditions of the experimental
model. In our case, the animals were "on" cardiopulmonary bypass (CPB). This
surgical procedure effectively removes the lungs from the cardiovascular system.
During CPB, Pang et al. [24] and Pitt et al. [25] found increased bradykinin and
prostaglandin levels in the circulating blood. These substances are normally ex-
tracted from blood as it passes through the pulmonary circulation. The elevated cir-
culating levels ofbradykinin and prostaglandins during CPB may have caused some
vasodilation and an increase in coronary vascular permeability. These effects may
explain the increased solute extractions that we observed under control CPB condi-
tions [21].
In our initial ischemia-reperfusion study [13] we found that the myocardial inulin
extraction decreased 38 percent during reperfusion but the albumin extraction
actually increased 45 percent during the same time period. We confirmed that this
curious finding was not caused by some artifactual rheologic problem and suggest
that two different microvascular alterations occurred simultaneously during reper-
fusion. Namely, coronary vascular permeability increased with time after ischemia,
despite the apparent decrease suggested by the inulin extraction data. Increased
vascular permeability after ischemia may appear to be fortuitous because it increases
myocardial exchange capacity, defined as the product of vascular permeability and
the exchanging vascular surface area(PS product). However, a marked permeability
increase leads to plasma protein leakage into the tissue space and edema [1,261.
Another deleterious consequence of increased permeability during reperfusion is
that interstitial solutes or those released from damaged myocytes are not restricted
from diffusing out of the tissue space into the plasma space. An example of this is
seen in the elevated levels of creatine kinase (CK-MB) found in coronary sinus ef-
fluent after a myocardial infarct. CK-MB is an 80,000 MW protein that does not
normally cross the cell wall of intact myocytes or intact microvasculature. Iron-
ically, coronary venous CK-MB levels serve as an excellent clinical measure of
myocardial damage from infarction or cardiac surgery [27].
In addition to increasing vascular permeability to both small and large solutes, the
observed decrease in inulin extraction during reperfusion suggested ischemia-
reperfusion caused a significant decrease in the exchanging vascular surface area.
This effect may have been caused by vascular plugging or a No-reflow phenomena
[8,9,10,11,28,29]. To assess the degree of No-reflow that follows moderate global
ischemia, we [30] measured perfused capillarity in rat hearts after 30 minutes of
ischemia and ten minutes ofreperfusion. Perfusedcapillaries were marked in a man-
ner similar to that employed earlier in skeletal muscle [31]. The results indicated that
the blue dye filled 1,800-2 300 coronary capillaries/mm2. No difference was ob-
served between subendocardial and subepicardial capillarity under control condi-
tions; however, after ischemia, we observed a marked decrease in perfused cap-
illarity: a 70 percent decrease in subepicardial capillarity (epi) and a 90-95 percent
decrease in the subendocardium (endo). The greater No-reflow in the endo samples
was statistically significant compared to that in the epi. Because these hearts were
beating but not ejecting, these results suggest that the endocardium was particularly
vulnerable to No-reflow. The differential effect may be caused simply by the ar-
chitecture ofthe coronary bed. With such a marked No-reflow throughout the heart
during reperfusion (70-95 percent), it is not surprising that cardiac function
deteriorated. Even if the myocyte were only mildly damaged by ischemia, the com-
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eventual cardiac necrosis. Recently Uretzky et al. [32] confirmed, using a different
model, that the No-reflow phenomena after mycocardial ischemia-reperfusion was
more pronounced in the endocardium. Furthermore, they found that the relatively
greater reduction in endocardial flow became worse as reperfusion continued. Our
finding of decreased inulin extraction and the later findings of Cohen et al. [30] and
Uretzky et al. [32] suggest that reperfusion makes matters worse. These findings
agree with other reports of "reperfusion injury" [33,34].
To determine if cold blood cardioplegia protects the heart and coronary microcir-
culation from ischemia-reperfusion, we [2] performed a study in which a group of
dogs was subjected to 45 minutes of global myocardial ischemia followed by reper-
fusion as described above. These hearts were treated, however, with a cold blood
cardioplegia solution consisting of pump blood from the extracorporeal circuit
cooled to 5°C with 30 meq/L potassium. Administration of cardioplegia was re-
peated after 15 and 30 minutes of ischemia. We found that the cold potassium car-
dioplegia caused some coronary vasoconstriction early during the reperfusion period
[35]. The vasoconstriction was in sharp contrast to the marked vasodilation observed
in the untreated group early in reperfusion. The coronary constrictor effort of the
blood cardioplegia abated with time, probably because of potassium washout. After
45 minutes of reperfusion, the coronary resistances of both groups were not dif-
ferent from their respective control values. Furthermore, for the cold cardioplegia
group, there was neither a decrease in inulin extraction nor an increase in myocardial
albumin extraction, as was observed for the unprotected group. In fact, the solute
exchange results for the cardioplegia group were quite similar to those seen in the
earlier control group which was simply placed on CPB with no ischemic period [21].
The cardioplegia study indicated that the cold blood recipe provided excellent pro-
tection of the coronary microcirculation despite a transient vasoconstriction. Fur-
thermore, it appears that platelets and white cells in blood cardioplegia do not in-
duce microthrombi development. Although cold blood cardioplegia is reported to
offer superior myocardial protection in comparison to crystalloid cardioplegia [36],
the underlying mechanisms are not known. Our studies suggest that improved
microvascular protection may be an important factor. Evidence for this suggestion
is described below and comes from studies in which we visualized directly the effects
of perfusate composition on coronary microvascular exchange and perfusion.
Direct Visualization of Coronary Microvascular Exchange and Perfusion
The studies described above indicated that solute delivery, solute extraction, and
the semipermeable barrier characteristics of the coronary microcirculation were
compromised severely after ischemia-reperfusion. Other workers report diminished
transcoronary exchange after low-flow ischemia and regional myocardial ischemia
and attribute the compromised exchange to reduced tissue uptake [37] or a
physiologic capillary derecruitment [38]. These possibilities may be valid, but they
cannot be tested with whole organ radio-tracer extraction techniques. Solute extrac-
tion from blood to tissue or vice versa is a function of blood flow, vascular
permeability, exchanging vascular surface area, and heterogeneity of perfusion.
Using whole organ radio-tracer techniques, one can only make a good guess as to the
actual cause(s) of an observed change in tracer extraction.
To determine the mechanisms underlying the microvascular damage caused by
ischemia, a simpler, more direct model was needed. Toward this end, we developed
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a model for direct visualization of the coronary microcirculation. Rat hearts were
initially perfused in situ with a Krebs blood solution high in potassium and then
isolated and placed on a special microscope stage. A conjugate of fluorescent
albumin (FITC-BSA) [39] was added to the perfusate and the epicardial microcir-
culation viewed by illuminating the fluorescent plasma with a high-quality
fluorescence microscope (Zeiss). In this manner, we were able to view the epicardial
microcirculation of the arrested heart with remarkable resolution. In preliminary
studies we observed that the fluorescent plasma protein (FITC-BSA) remained
largely intravascular only when the Krebs perfusate contained both red cells and
albumin. To quantify these effects, we developed a videodensitometric technique to
measure FITC-BSA extravasation [40].
Our initial direct visualization studies, in which the composition of the coronary
perfusate was varied, lead to the conclusion that coronary perfusion with a Krebs-
like solution causes a striking increase in coronary vascular permeability to
macromolecules. The observed protein effect and cell effect suggested that both
blood constituents had direct effects on the vascular wall [3]. The protein effect had
been demonstrated in other vascular beds [41] and in the heart for small solute ex-
change [42] but had not been previously demonstrated for macromolecular exchange
in the heart. We were concerned that these observations were artifactual and tested
the possibility that the increased vascular permeability with Krebs perfusion was
caused simply by hypoxia. A group of hearts was perfused with Fluosol-DA (Green
Cross, Inc.), which is an experimental blood substitute with increased oxygen-
carrying capacity and contains colloid (HES). We found that hearts perfused with
100 percent Fluosol-DA had much more FITC-BSA extravasation compared to
those perfused with the Krebs albumin-red cell solution [43]. A follow-up study in-
dicated that adding red cells and albumin to Fluosol-DA perfluorocarbons (PFC)
reduced the FITC-BSA leakage to a level similar to that observed with the Krebs-
BSA-RBC perfusate [44]. Thus the transcoronary macromolecular leakage observed
with pure Fluosol-DA was caused by the absence of albumin and red cells rather
than any toxic effects of Fluosol perfluorocarbons.
The increase in coronary vascular permeability to FITC-BSA caused by Krebs per-
fusion was striking and occurred rather quickly. These observations may explain the
superior cardiac protection of blood versus crystalloid cardioplegia. Crystalloid car-
dioplegia may increase coronary vascular permeability during cardiopulmonary
bypass because these solutions usually do not contain albumin and never contain
blood cells. Furthermore, because our earlier results indicated elevated coronary
vascular permeability from CPB alone, an additional increase in vascular permea-
bility would make these hearts particularly vulnerable. Cold blood cardioplegia may
protect vascular integrity by both its protein and cell effects. Such protection would
reduce the potential for a permeability edema [261 and perhaps minimize washout of
critical tissue solutes and enzymes such as CK-MB.
The direct visualization technique combined with the control afforded an isolated
perfused heart model lead to other interesting observations of the nature of cor-
onary microvascular damage that follows ischemia-reperfusion. In a study reported
recently [18], we found that ischemia-reperfusion led to marked transcoronary
FITC-BSA extravasation. These direct observations substantiated our earlier in-
direct measure of increased albumin extraction [2]. The direct visualization ex-
periments allowed a continual view of transcoronary FITC-BSA extravasation
during reperfusion. Early in reperfusion, no noticeable FITC-BSA leakage was ob-
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served; however, pronounced leakage was seen after ten minutes, and the leakage
appeared worse after 20 minutes of reperfusion. The increased extravasation with
time indicated that the extravascular FITC-BSA accumulation in the tissue space
may be caused by an ischemia-induced increase in permeability which was further in-
creased by reperfusion.
The second finding from the direct visualization study of ischemia-reperfusion
was that we did not observe a No-reflow phenomenon during reperfusion. Perfused
capillarity was determined by counting the number of red cell perfused capillaries
crossing a 200Am raster line positioned on the video monitor. We found no signifi-
cant decrease in this measure of capillarity during reperfusion [18]. This result was
in sharp contrast to our earlier findings of a 70 percent decrease in perfused
capillarity during reperfusion [30]. It occurred to us that the perfusate used in the
later study did not contain manyplatelets or white cells (about0.1 percent of normal
for each). On the other hand, in our earlier study, in which a marked No-reflow was
demonstrated, the hearts were perfused with whole blood from a support animal
[30]. These results suggest that platelets and/or white cells play a significant part in
the No-reflow phenomenon that follows myocardial ischemia. Recently, we per-
formed direct visualization, ischemia-reperfusion studies with platelets and white
cells in theK(2)RBC perfusate and did observe No-reflow. In several experiments we
also saw a morepronounced plasmaprotein leakage. These findings tend to support
the work ofSchmid-Schoenbein and Engler [45] who found leukocyte aggregation in
coronary microvessels after ischemia. Other hypotheses to explain the No-reflow
phenomena include: endothelial cell swelling [8], microvascular compression caused
by edema or myocardial contracture [29,46], and coronary vasospasm[11]. Our cur-
rent feeling is that microthrombi development is the principal cause.
To examine the role of calcium in the observed increase in coronary vascular
permeability after ischemia, we treated a group of rat hearts with a calcium blocker
(nisoldipine, Miles Laboratories,1 Atg/minute) for five minutes prior to ischemia.
The results were striking. Nisoldipine pretreatment prevented the FITC-BSA ex-
travasation caused by ischemia reperfusion. In contrast to the 76 percent increase in
transcoronary albumin (FITC-BSA) leakage (p < 0.01) measured during reperfu-
sion in the untreated group, we measured only a 3 percent (N.S.) increase in the
nisoldipine group [4]. These results implicate a calcium-mediated mechanism in
ischemia-induced vascular permeability alterations. One attractive speculation is
that the microvascular exchange vessels regulate large solute permeability by form-
inggaps between endothelial cells. Such ahypothesis was proposed earlier by Majno
et al. [47] to explain the action of histamine on microvascular permeability. It ap-
pears that vascular endothelial microfilaments do contain contractile proteins [48].
If endothelium can contract, and if it can change its shape, then interendothelial
gaps could indeed form, permitting macromolecular exchange.
Theexciting extension of the histamine response theory is that calcium influx into
endothelia may mediate this response. Calcium mediates contraction in cardiac,
skeletal, and smooth muscle. It may mediate endothelial contraction as well. It is
well established that, in ischemia, the myocyte cell wall permeability increases. The
increase in permeability leads to intracellular calcium accumulation [49]. Calcium
blockers are thought to protect the heart from damage by preventing this calcium in-
flux. Just as occurs in themyocyte, calcium mayenter vascular endothelium follow-
ing ischemia-reperfusion, either because of direct ischemic damage or reperfusion
injury caused by oxygen free radical formation [50]. In either case, this influx may
cause endothelial microfilament contraction and induce gap formation between
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vascular endothelium. This effect would alter microvascular exchange at the
capillary and venular level. It may also effect endothelium-mediated smooth muscle
contraction at the resistance vessel level [51,52]. Nisoldipine may have blocked
calcium uptake into endothelium and prevented gap formation. Further studies are
needed to confirm or reject this hypothesis, but one result is clear. In K(2)RBC per-
fused hearts, the calcium blocker nisoldipine did indeed prevent the coronary
permeability increase caused by ischemia-reperfusion. The underlying mechanisms
remain unexplained.
The studies described above delineate the nature of coronary microvascular
damage from ischemia and offer some hope that these deleterious effects can be
prevented or, at least, attenuated with pharmacologic agents. The truly exciting
challenge, which we hope to pursue, is to rank the underlying causes of
microvascular damage caused by ischemia and attempt to treat the worst offenders.
Protecting the heart from the deleterious effects of coronary disease and during car-
diac surgery is an important endeavor. Protecting the microcirculation of the heart
and other organs from ischemic damage will greatly facilitate overall organ
recovery. Furthermore, efforts aimed at preserving transplantable organs, such as
the liver, the kidneys, and the heart, should consider the critical role played by the
microcirculation in maintaining normal function.
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